More Than $10M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
Portfolio Pulse from Lisa Levin
Insiders at four companies, Kymera Therapeutics, STAAR Surgical, CVS Health, and V.F. Corporation, have recently made significant stock purchases. Kymera Therapeutics and STAAR Surgical saw purchases of $5.3 million and $10.8 million respectively, while CVS Health and V.F. Corporation saw smaller purchases of around $140,930 and $306,140 respectively. These purchases may indicate confidence in the companies' prospects.
November 07, 2023 | 11:33 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Director Edward J Ludwig of CVS Health purchased 2,000 shares at an average price of $70.47, costing around $140,930.
Insider purchases often indicate confidence in a company's prospects, which could potentially lead to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Director Mark Lampert of Kymera Therapeutics purchased 414,105 shares at an average price of $12.80, costing around $5.3 million.
Insider purchases often indicate confidence in a company's prospects, which could potentially lead to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
10% owner Neal Bradsher of STAAR Surgical purchased 309,154 shares at an average price of $34.93, costing around $10.8 million.
Insider purchases often indicate confidence in a company's prospects, which could potentially lead to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Director Matthew J Shattock of V.F. Corporation purchased 20,000 shares at an average price of $15.31, costing around $306,140.
Insider purchases often indicate confidence in a company's prospects, which could potentially lead to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100